Literature DB >> 7983294

Long-term urethral catheterization increases risk of chronic pyelonephritis and renal inflammation.

J W Warren1, H L Muncie, J R Hebel, M Hall-Craggs.   

Abstract

OBJECTIVE: To determine the prevalences of chronic pyelonephritis and chronic renal inflammation in elderly nursing home patients at the time of death and to assess correlation with urethral catheterization and other putative risk factors.
DESIGN: Prospective assessment of risk factors with the prevalences of chronic pyelonephritis and renal inflammation at autopsy.
SETTING: A 240-bed long-term care facility. PARTICIPANTS: All residents > or = 65 years old who died and were autopsied during a 2-year period. MEASUREMENTS: Antemortem assessment of risk factors for renal inflammation, including a search for any urethral catheterization in the person's life. Prospective assessment of urethral catheterization, catheter obstruction, and use of anti-inflammatory medications and urine cultures. Urinary tract pathology was assessed for gross and microscopic evidence of inflammation and urinary tract stones.
RESULTS: The duration of catheterization was significantly associated with increasing prevalence of bacteriuria, polymicrobial bacteriuria, chronic pyelonephritis, and chronic renal inflammation. The prevalence of chronic pyelonephritis at death was 10 percent (5/52) for patients catheterized > 90 days during their last year of life and zero (0/65) when catheterized < or = 90 days (P < 0.02; Fisher's exact test). Chronic pyelonephritis was significantly associated with renal stones and hydronephrosis. The prevalence of chronic renal inflammation without chronic pyelonephritis was significantly greater than that of chronic pyelonephritis: the prevalence was 43 percent (20/47) when catheterized > 90 days and 18 percent (12/65) when < or = 90 days (P < 0.05). Chronic renal inflammation was associated with hydronephrosis, ureteral dilatation, acute pyelonephritis and diastolic hypertension.
CONCLUSION: Chronic pyelonephritis and chronic renal inflammation are associated with long-term catheterization.

Entities:  

Mesh:

Year:  1994        PMID: 7983294     DOI: 10.1111/j.1532-5415.1994.tb06513.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  7 in total

1.  Decreased microbiota diversity associated with urinary tract infection in a trial of bacterial interference.

Authors:  Deborah Horwitz; Tyler McCue; Abigail C Mapes; Nadim J Ajami; Joseph F Petrosino; Robert F Ramig; Barbara W Trautner
Journal:  J Infect       Date:  2015-06-03       Impact factor: 6.072

2.  Development of an intranasal vaccine to prevent urinary tract infection by Proteus mirabilis.

Authors:  Xin Li; C Virginia Lockatell; David E Johnson; M Chelsea Lane; John W Warren; Harry L T Mobley
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 3.  Management of catheter-associated urinary tract infection.

Authors:  Barbara W Trautner
Journal:  Curr Opin Infect Dis       Date:  2010-02       Impact factor: 4.915

4.  Patient preferences and willingness to pay for innovations in intermittent self-catheters.

Authors:  Binny Pinder; Andrew J Lloyd; Beenish Nafees; Eric P Elkin; Jerome Marley
Journal:  Patient Prefer Adherence       Date:  2015-03-09       Impact factor: 2.711

5.  A Rare Cause of Death in a Woman: Iatrogenic Bladder Rupture in a Patient With an Indwelling Foley Catheter.

Authors:  Anthea B Mahesan Paul; Lary Simms; Abraham E Paul; Andrew A Mahesan; Ammani Ramzanali
Journal:  Urol Case Rep       Date:  2016-03-16

6.  Enhanced Recovery After Surgery for Breast Reconstruction: Pooled Meta-Analysis of 10 Observational Studies Involving 1,838 Patients.

Authors:  Ya-Zhen Tan; Xuan Lu; Jie Luo; Zhen-Dong Huang; Qi-Feng Deng; Xian-Feng Shen; Chao Zhang; Guang-Ling Guo
Journal:  Front Oncol       Date:  2019-07-30       Impact factor: 6.244

7.  Semi-Quantitative Assay to Measure Urease Activity by Urinary Catheter-Associated Uropathogens.

Authors:  Jesus M Duran Ramirez; Jana Gomez; Chloe L P Obernuefemann; Nathaniel C Gualberto; Jennifer N Walker
Journal:  Front Cell Infect Microbiol       Date:  2022-03-22       Impact factor: 6.073

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.